Reducing the burden of influenza-associated complications with antiviral therapy.
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsPlatelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in miceLymphocyte to monocyte ratio as a screening tool for influenzaThe novel influenza A (H1N1) virus pandemic: An update.Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations.Decision making with regard to antiviral intervention during an influenza pandemicSafety of oseltamivir in pregnancy: a review of preclinical and clinical data.Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort.Influenza: clinical symptoms, diagnostics and therapyOtolaryngological complications in patients infected with the influenza A (H1N1) virus.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.Pneumonia and influenza, and respiratory and circulatory hospital admissions in Belgium: a retrospective database study.Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infectionAnnual all-cause healthcare costs among influenza patients with and without influenza-related complications: analysis of a United States managed care database.Oseltamivir for influenza infection in children: risks and benefits.Incidence and Risk Factors of Pneumonia in Hospitalized Patients with Seasonal Influenza A or B.Delay in diagnosis of influenza virus in an elderly hospitalized patient: a fatal outcome.Impact of Patient Characteristics and Treatment Procedures on Hospitalisation Cost and Length of Stay in Japanese Patients with Influenza: A Structural Equation Modelling Approach.Influenza moves to the front of public health concerns.Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017.
P2860
Q21090775-82C89836-30BB-4ABC-AEB1-9788399E9740Q27312687-0EFACE00-4FB3-41F8-905F-27D76E5395DEQ28972265-1E799502-BB60-4B40-B64A-5DF7B9E33464Q30382148-27C85667-85AA-4180-BBD4-E482ECBB3920Q30386485-470EA70E-7139-43A1-AC3B-B6E16CFF108CQ30389010-AC4D3010-3DA8-4D36-8904-4850D69A4DF0Q30391173-ED0F1965-8415-4501-9A4E-A37E9D2D830BQ30391440-3802F9A1-B009-4966-AA05-0527CFBCD25EQ30391483-C6250F1A-773C-4700-B27A-4887CAA29FD2Q30394541-A3F63DB2-8D98-4AD7-BE86-A856078F78CCQ30403741-6A63701C-2EB0-458B-B4B3-896665131E20Q30405546-0EDAACDA-3336-4446-A7A1-8DC1A2016902Q30408146-1DAB7DAB-AC73-492A-A610-93DD17937B5CQ30409023-48358177-7D1F-4181-915A-4A2FF16F82E7Q35104497-620B9BF5-7A23-46E8-A7A9-EC0B94EC6D6EQ35193034-E386474B-D6AC-48EC-B1F9-9704C4A1FA57Q38093109-7625A0E2-AD9A-4C03-8FFD-2972C526744EQ38652336-521FA381-9456-4330-BA1B-CE01B8F6419AQ40041773-9D9D0C5D-B6DF-4022-9666-C476A16625FBQ40298677-AEA1F759-D1F9-4E4D-8EA1-E4CD408768A4Q41922261-97102003-0502-4F8A-B8C9-E6B024A9DB3BQ44787877-B24613A6-2801-4648-AF0B-1CE74A5FF8C9Q47627293-99F815C9-7F68-4952-8E9D-054A62DDAAB1
P2860
Reducing the burden of influenza-associated complications with antiviral therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reducing the burden of influenza-associated complications with antiviral therapy.
@en
Reducing the burden of influenza-associated complications with antiviral therapy.
@nl
type
label
Reducing the burden of influenza-associated complications with antiviral therapy.
@en
Reducing the burden of influenza-associated complications with antiviral therapy.
@nl
prefLabel
Reducing the burden of influenza-associated complications with antiviral therapy.
@en
Reducing the burden of influenza-associated complications with antiviral therapy.
@nl
P2860
P1433
P1476
Reducing the burden of influenza-associated complications with antiviral therapy.
@en
P2860
P2888
P304
P356
10.1007/S15010-009-8241-1
P577
2009-05-26T00:00:00Z